Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
Main Authors: | Robert J. Kimmerling, Mark M. Stevens, Selim Olcum, Anthony Minnah, Madeleine Vacha, Rachel LaBella, Matthew Ferri, Steven C. Wasserman, Juanita Fujii, Zayna Shaheen, Srividya Sundaresan, Drew Ribadeneyra, David S. Jayabalan, Sarita Agte, Adolfo Aleman, Joseph A. Criscitiello, Ruben Niesvizky, Marlise R. Luskin, Samir Parekh, Cara A. Rosenbaum, Anobel Tamrazi, Clifford A. Reid |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-01-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-022-04376-8 |
Similar Items
-
A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements
by: Robert J. Kimmerling, et al.
Published: (2022-11-01) -
Clinical value of CT-guided biopsy of small (≤1.5 cm) suspicious lung nodules: Diagnostic accuracy, molecular characterization and long-term clinical outcomes
by: Anobel Tamrazi, et al.
Published: (2022-01-01) -
Endovascular image-guided sampling of tumor-draining veins provides an enriched source of oncological biomarkers
by: Anobel Tamrazi, et al.
Published: (2023-03-01) -
Agnostic geophysics
by: A. Cook
Published: (1997-06-01) -
Class-agnostic counting
by: Lu, E, et al.
Published: (2019)